Pancreatic Cancer Research

ResearcherFlinders UniversityActive in the last 2 years

Mark E. Brooke‐Smith

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4229-7773; OpenAlex author ID A5042625391. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. Absolute risk of pancreatic cancer in people with acute pancreatitis - theAustralian experience. Co-author DOI 10.1016/j.hpb.2026.05.011↗
  2. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. Co-author DOI 10.1053/j.gastro.2021.09.022↗
  3. ROR1 and ROR2 expression in pancreatic cancer. Co-author DOI 10.1186/s12885-021-08952-9↗
  4. CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Co-author DOI 10.1038/s41467-019-10968-6↗
  5. A case of pancreatic cancer in the setting of autoimmune pancreatitis with nondiagnostic serum markers. Last author DOI 10.1155/2013/809023↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rachel Ε. Neale · 1 shared paper, 2026 · strength 0.26
  2. Richard C. Turner · 1 shared paper, 2026 · strength 0.26
  3. Savio George Barreto · 1 shared paper, 2026 · strength 0.26
  4. Minoti Vivek Apte · 1 shared paper, 2026 · strength 0.26
  5. Tony Pang · 1 shared paper, 2026 · strength 0.26
  6. Lucas Wigston · 1 shared paper, 2026 · strength 0.26
  7. Daniel Gerald Croagh · 1 shared paper, 2026 · strength 0.26
  8. Nam Quoc Nguyen · 1 shared paper, 2013 · strength 0.04
  9. Manju Dashini Chandrasegaram · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.